BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37903716)

  • 1. Wogonin Diminishes Radioresistance of Breast Cancer via Inhibition of the Nrf2/HIF-1[Formula: see text] Pathway.
    Wang T; Wang P; Wang S; Ma Y; Zhao Z; Long F
    Am J Chin Med; 2023; 51(8):2243-2262. PubMed ID: 37903716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
    Kamble D; Mahajan M; Dhat R; Sitasawad S
    Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of 4β-Hydroxywithanolide E from Physalis peruviana on the Nrf2-Anti-Oxidant System and the Cell Cycle in Breast Cancer Cells.
    Peng CY; You BJ; Lee CL; Wu YC; Lin WH; Lu TL; Chang FC; Lee HZ
    Am J Chin Med; 2016; 44(3):617-36. PubMed ID: 27109152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA Regulates Keap1/Nrf2 Signal Pathway by Activating Sestrin2 to Restrain Pulmonary Fibrosis.
    Li H; Wu M; Guo C; Zhai R; Chen J
    Am J Chin Med; 2022; 50(8):2125-2151. PubMed ID: 36309810
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Emmanuel N; Li H; Chen J; Zhang Y
    Oncotarget; 2022 Oct; 13():1136-1139. PubMed ID: 36264074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis.
    Zhang HS; Zhang ZG; Du GY; Sun HL; Liu HY; Zhou Z; Gou XM; Wu XH; Yu XY; Huang YH
    J Cell Mol Med; 2019 May; 23(5):3451-3463. PubMed ID: 30809937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.
    Zhong Y; Zhang F; Sun Z; Zhou W; Li ZY; You QD; Guo QL; Hu R
    Mol Carcinog; 2013 Oct; 52(10):824-34. PubMed ID: 22593043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maslinic Acid Ameliorates Myocardial Ischemia Reperfusion Injury-Induced Oxidative Stress via Activating Nrf2 and Inhibiting NF-[Formula: see text]B Pathways.
    Li Q; Li Z; Liu C; Xu M; Li T; Wang Y; Feng J; Yin X; Du X; Lu C
    Am J Chin Med; 2023; 51(4):929-951. PubMed ID: 36974993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
    Urpilainen E; Kangaskokko J; Puistola U; Karihtala P
    Tumour Biol; 2019 Jan; 41(1):1010428318815413. PubMed ID: 30803422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.
    Zhang P; Singh A; Yegnasubramanian S; Esopi D; Kombairaju P; Bodas M; Wu H; Bova SG; Biswal S
    Mol Cancer Ther; 2010 Feb; 9(2):336-46. PubMed ID: 20124447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.
    Xu X; Zhang Y; Li W; Miao H; Zhang H; Zhou Y; Li Z; You Q; Zhao L; Guo Q
    Biochem Pharmacol; 2014 Nov; 92(2):220-34. PubMed ID: 25264278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
    Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.
    Cheng KC; Lin RJ; Cheng JY; Wang SH; Yu JC; Wu JC; Liang YJ; Hsu HM; Yu J; Yu AL
    EBioMedicine; 2019 Jul; 45():25-38. PubMed ID: 31262713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes.
    Khan NM; Haseeb A; Ansari MY; Devarapalli P; Haynie S; Haqqi TM
    Free Radic Biol Med; 2017 May; 106():288-301. PubMed ID: 28237856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Role of
    Yu P; Li J; Luo Y; Sun J; Hu Y; Lin B; Meng X; Xiang L
    Am J Chin Med; 2023; 51(2):279-308. PubMed ID: 36655686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.